EIElena Ivanovna Isayeva

Elena Ivanovna Isayeva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Elena Ivanovna Isayeva has a total of 182 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Monitoring of respiratory viral infections in Moscow during 2011–2022

    by Elizaveta N. Vetrova, Alyona I. Chernyshova, Tatiana N. Pritchina, Elena I. Isaeva, Olga V. Morozova

    Introduction. Respiratory viruses (RV) circulate throughout the world and in all seasons of the year. Long-term monitoring of the distribution of respiratory pathogens is necessary to analyze the relevance of diagnostic systems to current viral isolates, to assess the risks of infection and the need for vaccine development and use, as well as to investigate the interdependence of RV reproduction in mixed infections. Objective — to study the causative agents of acute respiratory viral infections (ARVI) in Moscow during 2011–2022 by reverse transcription with subsequent polymerase chain reaction with fluorescent hydrolysis probes detection in real-time (RT2-PCR). Materials and Methods. Nasopharyngeal swabs from 3908 patients with acute respiratory infections were examined by the RT2-PCR. Results. Monitoring of RV spread in Moscow showed cyclical changes in frequencies with three dominant species: influenza A virus (up to 31.3%), respiratory syncytial virus (up to 24.8%) and human rhinoviruses (up to 21.3%) in 2011–2020. The increase in the portion of unidentified clinical specimens from 1.2 to 28.5% in 2022 indicated incomplete accordance of diagnostic systems to modern RV isolates or the emergence of new species or strains of pathogens. Unidirectional changes in dynamics were registered for 5 out of 9 studied RVs with correlation coefficients of 0.43–0.79. High frequencies of mixed acute respiratory viral infections (up to 33.4%) along with unidentified samples do not allow us to accurately assess the risks of infection with various RV in Moscow, but prove the necessity of preventing infectious diseases with the most common RV. Conclusion. Analysis of the dynamics of RV frequencies in Moscow showed the preservation of the dominant species: influenza A virus, respiratory syncytial virus and human rhinoviruses. During the period of vaccination against COVID-19, the proportion of seasonal coronaviruses increased.


  • RESISTANCE OF INFLUENZA VIRUSES TO ETIOTROPIC DRUGS

    by Г.в. Лукманова, Н.г. Кливлеева, Т.и. Глебова, А.а. Айтжанова, Н.с. Онгарбаева, М.г. Шаменова, Д.а. Исмагулова, Е.и. Исаева

    Респираторные вирусные инфекции, являясь наиболее распространенными среди всех заболеваний человека, наносят огромный ущерб здоровью людей и экономике. Социркуляция разных вирусов и вариативность их соотношения от сезона к сезону осложняет подбор средств для профилактики и лечения. Кроме того, часто имеет место инфицирование вирусами с устойчивостью к специфическим препаратам. Проблема резистентности инфекционных агентов к лекарственным средствам на сегодняшний день является одной из главных задач, стоящих перед биологическими и медицинскими науками. Лекарственная устойчивость вирусов является результатом изменений их наследственных свойств и нередко связана с избыточным использованием препаратов. Вероятность появления устойчивых к препаратам штаммов вирусов нарастает с увеличением продолжительности лечения в клинической практике. Наряду с этим, более 30% резистентных штаммов обнаруживается у больных, никогда не принимавших этиотропные препараты. Поэтому важно выявить соотношение чувствительных и устойчивых штаммов в популяции, изучить механизмы возникновения устойчивости и возможные способы её преодоления. Вирусы гриппа, изолированные в Казахстане с 2015 г., проявляют чувствительность к препаратам на основе озельтамивира и широкий спектр восприимчивости к препаратам адамантанового ряда. Изучение чувствительности аборигенных вирусов к противовирусным препаратам предоставляет информацию для формирования рекомендаций по использованию лекарственных средств для лечения и профилактики гриппозной инфекции у населения. Рациональное использование и подбор лекарственных средств может позволить снизить экономические потери, связанные с временной нетрудоспособностью части населения в эпидемический период. Respiratory viral infections, being the most widespread among all diseases in humans, cause enormous damage to human health and the economy. The co-circulation of various viruses and the variability of their correlation from season to season complicate the selection of agents for the prevention and treatment. In addition, infection with viruses that are resistant to specific drugs occurs frequently. Drug resistance in infectious agents is one of the major challenges of our time facing the biological and medical sciences. Drug resistance among viruses is the outcome of changes in their hereditary properties and is often associated with excessive use of medicines. The likelihood of the emergence of drug-resistant strains increases with the treatment duration in clinical practice. At the same time, more than 30% of resistant strains are found in patients who have never taken etiotropic drugs. It is therefore important to reveal the correlation between sensitive and resistant strains in the population and to understand the mechanisms for the emergence of resistance and possible ways to overcome it. Influenza viruses isolated in Kazakhstan since 2015 reveal sensitivity to oseltamivir-based drugs and a wide range of susceptibility to adamantane drugs. Study of the sensitivity of native viruses to antiviral drugs provides information for the formation of recommendations for the use of drugs intended to treat and prevent influenza infection in the population. Rational use and selection of drugs can reduce economic losses associated with a temporary disability among a part of the population during the epidemic period.

  • Open Access

    Study of the Antiviral Activity of Adamantane-Containing Chemical Compounds

    by I. I. Lyubimov, E. I. Isaeva, E. N. Vetrova, A. V. Lavrova, N. M. Gretskaya, I. V. Serkov, V. V. Bezuglov, G. A. Galegov

    Исследование антивирусной активности адамантансодержащих химических соединений


  • Open Access

    The role of active herpesvirus infection in the formation of atopic dermatitis and psoriasis

    by T. V. Solomay, T. A. Semenenko, S. L. Vedunova, E. I. Isaeva, E. N. Vetrova, N. V. Karazhas

    Роль активной герпес-вирусной инфекции в формировании атопического дерматита и псориаза


  • Comparing the efficacy of meglumine acridon acetate and pentanedioic acid imidazolyl ethanamide in the outpatient treatment for ARVI during the COVID-19 pandemic

    by M.S. Savenkova, E.N. Vetrova, E.I. Isaeva, G.N. Kraseva, Clinical And Diagnostic Center Of Gazprom Polyclinic No 2, N.A. Abramova, M.B. Shabat, R.V. Dushkin, S. Fadeeva, S.V. Kontio

    This study compared the efficacy of different therapies for ARVI during the COVID-19 pandemic. Objective. To compare clinical efficacy of Cycloferon and Ingavirin in children aged 4–17 years treated in outpatient facilities during the epidemic season of СOVID-19. Patients and methods. This study included 101 patients who provided 143 oro- and nasopharyngeal swabs tested using certified PCR tests. Of them, 128 samples (89.5%) were positive, whereas 15 samples (10.5%) were negative. We identified the most common viruses circulating in January–May 2021, including (seasonal) coronaviruses (35.9%), rhinoviruses (20.3%), and other viruses. We also analyzed respiratory viruses that have circulated in Moscow during the last 6 years and found higher levels of seasonal coronaviruses. The most common ARVI symptoms in 2021 were fever, rhinitis, pharyngeal hyperemia, and fatigue. Fewer children had headache, cough, and enlarged lymph nodes. Results. We compared ARVI treatment with broad-spectrum antivirals in children aged between 4 and 17 years. Children in group 1 (n = 51) received Cycloferon®, while children in Group (n = 50) received Ingavirin®. Study participants were diagnosed with ARVI and moderate nasopharyngitis. Children from the Cycloferon group demonstrated a more significant dynamics of such clinical symptoms as headache (p < 0.05), cough (p < 0.01), rhinitis (p < 0.01), abundant mucus (p < 0.001), and enlarged lymph nodes (p < 0.001) than children from the Ingavirin group (there was a significant difference in the duration of these symptoms). Only 2 children from group 1 required antibiotics (3.4%), whereas in group 2, 11 children needed antibacterial therapy (22%). Key words: children, acute respiratory viral diseases (ARVI), COVID-19, PCR diagnostics, clinical manifestations, Cycloferon, Ingavirin


  • Open Access

    Effect of Tilorone on the Dynamics of Viral Load and the Levels of Interferons and Interleukin-1β in the Lung Tissue and Blood Serum of Mice with Experimental Influenza

    by O. V. Kalyuzhin, E. I. Isaeva, E. N. Vetrova, A. I. Chernysheva, L. O. Ponezheva, A. V. Karaulov

    We studied the effect of tilorone on the dynamics of IFNα, IFNγ, and IL-1β levels in the lung tissue and blood serum in relation to viral load in the lungs of BALB/c mice with pneumonia caused by influenza virus A/Aichi/2/68 (H3N2). Tilorone was administered per os in doses of 40, 150, and 540 μg per mouse 6, 30, and 78 h postinfection, which simulated the drug regimen used in the clinic for the treatment of influenza and acute respiratory viral infections in Russia and post-Soviet countries. Tilorone reduced viral load with the maximum amplitude (2-3 lg) after 1-2 administrations. The results of studying the dynamics of the cytokine levels in the infected animals in general support the previous hypothesis that, in repeated dosing, tilorone enhances the IFN response (compensates for its deficiency) at the early stages of acute respiratory viral infections and suppresses (damps) excessive production of IFN and proinflammatory cytokines at the later stages.


  • Evaluation of the effectiveness of chemical disinfection agents against the Epstein-Barr virus

    by Interregional Department No. 1 of the FMBA of Russia, Tatiana Valerievna Solomay, Elena Ivanovna Isayeva, FGBU "National Research Center of Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya" of the Ministry of Health of the Russian Federation, Elizaveta Nikolaevna Vetrova, Alyona Igorevna Chernyshova, Tatyana Anatolievna Semenenko, I.M. Sechenov First Moscow State Medical University (Sechenov University), Lyudmila Grigoryevna Panteleyeva, Scientific Research Disinfectology Institute of Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing

    The widespread spread of infection caused by the Epstein-Barr virus (EBV), the lack of registered vaccines, the possibility of implementing a transmission mechanism in medical organizations, determine disinfection as the main method of preventing this disease. The aim is to evaluate the effectiveness of chemical disinfection agents approved for use in the Russian Federation in relation to EBV-infected cell culture with quantitative DNA determination by polymerase chain reaction. Working solutions of complex disinfectants used for the treatment of medical devices were introduced into samples of EBV-infected B-cell culture in the concentration and exposure specified in the instructions (0.1 %; 60 min.). Then, the quantitative determination of the EBV DNA was performed. Chlorine-containing disinfectants, combined preparations based on aldehydes and guanidines per hour, as well as guanidines per hour and triamines, provided complete destruction of genetic material, while the combination of H with triamines led only to a decrease in the concentration of EBV DNA from 5.0 · 106 copies/ml to 2.4 · 106 copies/ml (by 2.1 times), which may not be enough to fully ensure biological safety when processing medical devices (sensors of ultrasound diagnostics devices, etc.), which are not subject to sterilization. The inability to determine the viability of EBV after treatment with disinfectants due to the initial presence of the virus in the B-cell culture makes the molecular biological method the only acceptable one at this stage and requires the search for new models – cell cultures intact to EBV or biological objects (laboratory animals). Keywords: Epstein-Barr virus, disinfection, quaternary ammonium compounds, triamines, aldehydes, guanidines, active chlorine releasing agents.


  • INFLUENZA A AND B VIRUSES CIRCULATING IN THE TERRITORY OF SOUTHERN KAZAKHSTAN DURING 2020-2021 EPIDEMIC PERIOD

    by С.б. Байсейiт, А.м. Баймухаметова, Г.в. Лукманова, Н.т. Сактаганов, Д.а. Исмагулова, Т.и. Глебова, Н.г. Кливлеева, Е.и. Исаева

    В статье показаны результаты мониторинга циркуляции разных серотипов вируса гриппа на территории южного Казахстана в эпидемический период 2020-2021 гг. С этой целью в период с декабря 2020 г. по февраль 2021 г. в лечебных учреждениях различных регионов южного Казахстана от больных людей получено 370 носоглоточных смывов. При скрининге образцов в полимеразной цепной реакции в режиме реального времени обнаружен генетический материал как вируса гриппа А (8,11% случаев), так и вируса гриппа В (5,14%). При субтипировании образцов, положительных на грипп типа А, РНК вируса гриппа A/H1N1/pdm выявлена в 2,97% проб, A/H3N2 – в 3,51%. В результате последовательных пассажей биопроб на куриных эмбрионах выделено три гемагглютинирующих агента, идентифицированных в реакции торможения гемагглютинации и реакции ингибиции нейраминидазной активности как вирусы гриппа А/H1N1pdm, А/H3N2 и типа В. This paper demonstrates the results of monitoring the circulation of different serotypes of influenza virus in the territory of the southern Kazakhstan during the 2020-2021 epidemic period. For this purpose, 370 nasopharyngeal swabs were obtained from patients in healthcare facilities located in various regions of the southern Kazakhstan during the period from December 2020 to February 2021. Screening of samples in real-time polymerase chain reaction has revealed genetic material of both influenza A virus (8.11% of cases) and influenza B virus (5.14%). When subtyping samples positive for influenza type A, the influenza A/H1N1/pdm virus RNA have been detected in 2.97% of samples, while that from the A/H3N2 virus in 3.51%. As a result of successive passages of biosamples in chicken embryos, three hemagglutinating agents have been isolated and identified in the hemagglutination inhibition assay and the neuraminidase inhibition assay as influenza A/H1N1pdm, A/H3N2, and type B viruses.

  • Innate and adaptive immunity during infection and immunization with inactivated tick-borne encephalitis vaccine

    by Olga Vladimirovna Morozova, Elena Ivanovna Isaeva

    Введение. При вирусных инфекциях Т-клеточный и гуморальный иммунитет обеспечивают элиминацию вирусов. Внеклеточная презентация антигенов вакцин на основе вирионов, инактивированных формальдегидом, вызывает преимущественно гуморальный иммунитет с риском персистентной инфекции. Цель: сравнение динамики цитокинов и антител классов IgM и IgG при инфекции и в результате иммунизации лабораторных мышей инактивированной вакциной против клещевого энцефалита. Методы: обратная транскрипция с последующей ПЦР с гибридизационно-флуоресцентной детекцией продуктов в реальном времени (ОТ-ПЦР-РВ); иммуноферментный анализ (ИФА) для определения антител классов IgM и IgG. Результаты. При инфекции обнаружены мРНК всех исследованных цитокинов, а после вакцинации отсутствовали РНК IL1P, IL4 и TNFa. При инфекции экспрессия генов цитокинов начиналась через 1-2 сут с максимумами через 4-8 дней, а при иммунизации выявлена только через 14 сут и продолжалась в течение 42 дней наблюдений, возможно, вследствие 3-кратной вакцинации. Антитела при инфекции также регистрировали раньше, через 7-14 сут, а после вакцинации позже - через 28-42 сут и титры были выше. Заключение. При вирусной инфекции спектры цитокинов более разнообразны, трансрипция РНК цитокинов и секреция антител классов IgM и IgG происходила раньше, чем при вакцинации. Титры антител были выше при внутримышечных инъекциях вакцины по сравнению с инфекцией с длительной циркуляцией IgM в течение 42...


  • Open Access

    In Vitro Study of Picloxidine 0.05 % Antiviral Activity (on the Example of Adenovirus)

    by G. M. Chernakova, D. Yu. Maychuk, E. A. Klescheva, M. V. Mezentseva, L. I. Russu, I. A. Suetina, E. I. Isaeva, Д. Ю. Майчук

    Изучение in vitro противовирусной активности пиклоксидина 0,05 % (на примере аденовируса)